Browsing by Author Marshall, Helen
Showing results 1 to 3 of 3
Issue Date | Title | Author(s) |
---|---|---|
1-Nov-2018 | Benefits and risks of adjuvant treatment with zoledronic acid in stage II/III breast cancer. 10 years follow-up of the AZURE randomized clinical trial (BIG 01/04) | Coleman, Robert E.; Collinson, M.; Gregory, W.; Marshall, Helen; Bell, Richard; Dodwell, David; Keane, Maccon; Gil Gil, Miguel; Barrett-Lee, Peter J.; Ritchie, Diana; Bowman, A.; Liversedge, V.; Boer, R. H. de; Passos Coelho, J. L.; O'Reilly, S.; Bertelli, G.; Joffe, J.; Brown, J. E.; Wilson, C.; Tercero, J. C.; Jean Mairet, J.; Gomis, R.; Cameron, David |
13-Oct-2011 | Breast-cancer Adjuvant Therapy With Zoledronic Acid | Coleman, Robert E.; Marshall, Helen; Cameron, David; Dodwell, David; Burkinshaw, Roger; Keane, Maccon; Gil Gil, Miguel; Houston, Stephen J.; Grieve, Robert J.; Barrett-Lee, Peter J.; Ritchie, Diana; Pugh, Julia; Gaunt, Claire; Rea, Una; Peterson, Jennifer; Davies, Claire; Hiley, Victoria; Gregory, Walter; Bell, Richard |
4-Dec-2017 | Congenital microcephaly: Case definition & guidelines for data collection, analysis, and presentation of safety data after maternal immunisation | DeSilva, Malini; Muñoz, Flor M.; Sell, Erick; Marshall, Helen; Tse Kawai, Alison Tse; Kachikis, Alisa; Heath, Paul T.; Klein, Nicola P.; Oleske, James M.; Jehan, Fyezah; Spiegel, Hans; Nesin, Mirjana; Tagbo, Beckie N.; Shrestha, Anju; Cutland, Clare L.; Eckert, Linda O.; Kochhar, Sonali; Bardají, Azucena; Brighton Collaboration Congenital Microcephaly Working Group |